Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$5.5M |
 |
Gilead SciencesGILD |
-$4.04B |
 |
AmgenAMGN |
-$189M |
 |
Editas MedicineEDIT |
-$7M |
 |
Crispr TherapeuticsCRSP |
-$171M |
Are Larimar Therapeutics Insiders Buying or Selling?
Larimar Therapeutics (LRMR) has had no reported insider transactions in the past 90 days. The most recent was Hamilton Thomas Edward, who bought 50,000 shares at $3.34 on July 6, 2026.
Insider trading patterns can signal confidence or concern from the people who know the company best. AltIndex tracks insider transactions as one of 25+ alternative data signals in the LRMR AI Score. For government officials trading this stock, see LRMR congressional trading.
Who’s Trading Larimar Therapeutics Stock?
| Insider | Activity | Trades | Last Trade |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. | Bought $55M | 7 | Feb 27, 2026 |
| Hamilton Thomas Edward | Bought $670,000 | 2 | Jul 6, 2026 |
| JEFFREY SHERMAN | Bought $25,000 | 1 | Feb 27, 2026 |
| FRANK THOMAS | Bought $25,000 | 1 | Feb 27, 2026 |
Recent Larimar Therapeutics Insider Transactions
| Insider | Transaction Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Hamilton Thomas Edward | Jul 6, 2026 | Buy | 50,000 | $3.34 | $170,000 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | Feb 27, 2026 | Buy | 2,000,000 | $5 | $10M |
| DEERFIELD MANAGEMENT COMPANY, L.P. | Feb 27, 2026 | Buy | 1,084,012 | $5 | $5.4M |
| DEERFIELD MANAGEMENT COMPANY, L.P. | Feb 27, 2026 | Buy | 1,084,010 | $5 | $5.4M |
| DEERFIELD MANAGEMENT COMPANY, L.P. | Feb 27, 2026 | Buy | 831,978 | $5 | $4.2M |
| Hamilton Thomas Edward | Feb 27, 2026 | Buy | 100,000 | $5 | $500,000 |
| FRANK THOMAS | Feb 27, 2026 | Buy | 5,000 | $5 | $25,000 |
| JEFFREY SHERMAN | Feb 27, 2026 | Buy | 5,000 | $5 | $25,000 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | Jul 31, 2025 | Buy | 3,387,539 | $3.2 | $11M |
| DEERFIELD MANAGEMENT COMPANY, L.P. | Jul 31, 2025 | Buy | 3,387,529 | $3.2 | $11M |
| DEERFIELD MANAGEMENT COMPANY, L.P. | Jul 31, 2025 | Buy | 2,599,932 | $3.2 | $8.3M |
Frequently Asked Questions: Larimar Therapeutics Insider Trading
Larimar Therapeutics insiders have not reported any transactions in the past 90 days.
Insider buying is generally a stronger signal than insider selling, since insiders may sell for personal reasons (diversification, taxes) but typically buy only when they believe the stock is undervalued. AltIndex uses insider transaction patterns alongside 25+ other signals in the AI Score.
DEERFIELD MANAGEMENT COMPANY, L.P. has bought the most LRMR stock in the last 2 years, with a total value of $55M.
According to our estimates, the total value of insider transactions for Larimar Therapeutics in the last 2 years is positive, amounting to $56M. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
